Akzo Nobel N V S/Adr
(AKZOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,220,520 | 1,115,040 | 1,191,900 | 2,302,340 | 1,479,490 |
| Receivables | 3,390,090 | 3,674,790 | 3,650,210 | 3,646,260 | 3,931,600 |
| Inventories | 1,759,020 | 1,818,590 | 1,922,170 | 2,053,760 | 2,095,170 |
| Other current assets | 90,120 | 102,890 | 191,890 | 204,730 | 189,760 |
| TOTAL | $6,459,750 | $6,711,310 | $6,956,170 | $8,207,090 | $7,696,020 |
| Non-Current Assets | |||||
| Investments And Advances | 0 | 0 | 0 | 243,260 | 0 |
| Other Non-Current Assets | 6,831,360 | 6,846,260 | 7,636,770 | 8,118,030 | 7,819,410 |
| TOTAL | $6,831,360 | $6,846,260 | $7,636,770 | $8,361,290 | $7,819,410 |
| Total Assets | $17,620,240 | $17,976,850 | $19,163,060 | $21,666,260 | $20,548,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,788,400 | 3,849,570 | 3,903,040 | 4,528,920 | 4,454,400 |
| Accrued Expenses | 0 | 0 | 0 | 301,750 | 0 |
| Other current liabilities | 697,600 | 784,290 | 774,280 | 671,290 | 1,040,280 |
| TOTAL | $5,223,650 | $5,700,240 | $5,581,420 | $6,580,030 | $6,659,710 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,404,320 | 2,413,720 | 2,860,120 | 3,359,140 | 2,704,220 |
| Other Non-Current Liabilities | 2,759,240 | 2,804,210 | 3,128,750 | 2,848,680 | 3,217,730 |
| TOTAL | $5,163,560 | $5,217,930 | $5,988,870 | $6,755,490 | $5,921,950 |
| Total Liabilities | $10,387,230 | $10,918,190 | $11,570,300 | $13,335,530 | $12,581,660 |
| Shareholders' Equity | |||||
| Common Shares | 552,960 | 549,780 | 555,320 | 654,010 | 651,500 |
| Retained earnings | 0 | 0 | 0 | 6,509,580 | 0 |
| Other shareholders' equity | 6,052,550 | 5,884,990 | 6,514,860 | 551,670 | 6,741,980 |
| TOTAL | $7,233,010 | $7,058,660 | $7,592,760 | $8,330,720 | $7,966,700 |
| Total Liabilities And Equity | $17,620,240 | $17,976,850 | $19,163,060 | $21,666,250 | $20,548,360 |